By Stephen Nakrosis

Shares of Athersys Inc. had been buying and selling decrease in Thursday’s after-hours market, following information the corporate might be conducting a 1-for-25 reverse inventory break up.
Athersys stated “the reverse inventory break up is primarily supposed to convey the corporate into compliance with Nasdaq’s minimal bid worth requirement.”

The regenerative medication firm stated it would execute the reverse break up after the shut of enterprise on Aug. 26. Shares are anticipated to start buying and selling on a split-adjusted foundation on Aug. 29.
At 5:10 p.m. ET, Athersys shares had been buying and selling 12.47% decrease at 15 cents a share. The inventory completed the day’s common session with a 2.29% loss, closing at 17 cents a share.
12 months up to now, the inventory has fallen over 80%.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com